Ipamorelin

Ipamorelin is a peptide and a growth hormone secretagogue and it is quite popular for its safety. Ipamorelin is actually known for its cleanliness and safeness in the world of GHRP’s. In addition to this, ipamorelin does not entail the side-effect of elevated hunger like other GHRP’s.

In fact, ipamorelin has a lot going for it compared to other GHRP’s.Clinical research studies have shown that Ipamorelin can help to increase LBM (lean body mass) and lower body fat. These studies have also shown that Ipamorelin can help to improve sleep and mood as well without any spike in cortisol or prolactin, when administered at lower doses.

Despite the fact that scientists know more about ipamorelin than other peptides, research has not ceased to be pursued. According to the University of Queensland School of Medicine Ochsner Clinical School, ipamorelin has been shown to aid in the management of postoperative ileus in bowel resection patients. In this study, Ipamorelin was shown to be tolerable as taken twice daily for seven days.Learn more additional details at https://www.peptidesciences.com/ipamorelin

Although there was no significant difference between that of the ipamorelin and the placebo, there were signs that ipamorelin possesses attributes that could be tested further with more positive results.

Another study conducted by the University of Aarhus showed some more promising results. A group of 8-month-old female rats underwent ipamorelin injections three times daily for 3 months. After this test time, ipamorelin showed to counteract the effects of glucocorticoid on skeletal muscles as well as bones.Basically, ipamorelin showed to be a great aid in reversing the effects of decreased muscle strength and bone deformation.

Ipamorelin

Anderson, N.B., et al. “Regular Article: The Growth Hormone Secretagogue Ipamorelin Counteracts Glucocorticoid-Induced Decrease in Bone Formation of Adult Rats.” Growth Hormone & IGF Research 11.(2001): 266-272. ScienceDirect. Web. 15 July 2016.

Beck, David E, Brian Sweeney, and Martin D McCarter. “Prospective, Randomizes, Controlled, Proof-of-Concept Study of the Ghrelin Mimetic Ipamorelin for the Management of Prosoperative Ileus in Bowel Resection Patients.” International Journal of Colorectal Disease. 29.12 (2014): 1527-1534. Webline. 15 July 2016.

KB. “iPamorelin Facts Explained.” Evolutionary.org. Web. 15 July 2016.